Studie-index
0-9 | A | B |C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z

Studie
MAAS
Multicentre Anti-Atheroma Study
simvastatine
MSD
MACH-1
Mortality Assessment in Congestive Heart failure
mibefradil
Roche
MADIT
Multicenter Automatic Defibrillator Implantation Trial
MAPHY
Metoprolol Atherosclerosis Prevention in Hypertensives study
metoprolol, hydrochloorthiazide, bendroflumethiazide
AstraZeneca, Novartis, Leo
MARCATOR
Multicenter American Research trial with Cilazapril after Angioplasty to prevent Transluminal coronary Obstruction and Restenosis
cilazapril
Roche
MARS
Monitored Atherosclerosis Regression Study
MAST-1
Multicenter Acute Stroke Trial - Italy
MATH
Modern Approach to the Treatment of Hypertension
McSPI
Multicenter Study of Perioperative Ischemia
MDC
Metoprolol in Dilated Cardiomyopathy trial
MDPIT
Multicenter Diltiazem Post-Infarction Trial
MEHP
Metoprolol in Elderly Hypertension Patients
MERCATOR
Multicenter European Research trial with Cilazapril after Angioplasty to prevent Transluminal coronary Obstruction and Restenosis
MERIT-HF
Metoprolol CR/XL Randomised Intervention
metoprolol
AstraZeneca
MEXIS
Metoprolol and Xamoterol Infarction Study
metoprolol
AstraZeneca
M-HEART
Multi-Hospital Eastern Atlantic Restenosis Trial
M-HEART-II
Multi-Hospital Eastern Atlantic Restenosis Trial II
aspirine
Generiek
MHFT
Munich Mild Heart Failure Trial
captopril
Bristol-Myers Squibb
MIAMI
Metoprolol In Acute Myocardial Infarction trial
metoprolol
AstraZeneca
MICRO-HOPE
Microalbuminuria, Cardiovascular and Renal Outcomes in the Heart Outcomes Prevention Evaluation
ramipril
Aventis
MIDAS
Multicenter Isradipine/Diuretic Atherosclerosis Study
isradipine , hydrochloorthiazide
Novartis, Novartis
MIRACL
Myocardial Ischaemia Reduction with Aggressive Cholesterol Lowering
atorvastatine
Pfizer
MIRSA
Multicenter International Randomized Study of Angina pectoris
bisoprolol, atenolol
Merck, AstraZeneca
MITI-2
Myocardial Infarction Triage and Intervention project - phase II
alteplase, aspirine
Boehringer Ingelheim, Generiek
MOCHA
Multicenter Oral Carvedilol Heart failure Assessment
carvedilol
Roche
MONICA
Monitoring trends and determinants in Cardiovascular disease
MRFIT
Multiple Risk Factor Intervention Trial
hydrochloorthiazide, chloortalidon
Novartis, Novartis
MUSTT
Multicenter Unsustained Tachycardia Trial
disopyramide, propafenon, sotalol, amiodaron, mexiletine, acebutolol, proca´namide
HMR, Knoll, Bristol-Myers Squibb, Sanofi, Boehringer Ingelheim, Rhone-Poulenc Rorer, Bristol-Myers Squibb